Where does the President Stand?

In the previous post, we note that the President during his comments to the AARP meeting, did not speak forcefully for price negotiation for prescription medicines in Part D, only indicating that further price reductions might be possible. On July 29 in Raleigh, he came out more forceful for price negotiation. Is a stronger statement on the right and value of personal importation of medicines next? And, what will be PhRMA's reaction to the following comment?

12:57 p.m. - A male doctor asks about the "high costs of prescription drugs in America." Obama says the U.S. spends 77 percent more for drugs than any other country. Says the prescription drug bill passed a few years back prohibited Medicare from negotiating with drug companies for lower prices, something that needs to be included in a new health care bill. Does laud the drug companies for offering lower costs as part on the ongoing negotiations in Congress.